Keyphrases
Peroxisome Proliferator-activated Receptor
100%
Diabetic Nephropathy
100%
Type 2 Diabetic Patients
100%
Receptor 2
100%
Decreased Risk
100%
Pro12Ala Polymorphism
100%
Albumin Excretion Rate
75%
Control Subjects
50%
Diabetes Duration
50%
Diabetes
25%
Dialysis
25%
Blood Pressure
25%
Proteinuria
25%
Hemoglobin A1c (HbA1c)
25%
Genomic DNA (gDNA)
25%
Fasting Plasma Glucose
25%
Odds Ratio
25%
Diabetic Patients
25%
Serum Creatinine
25%
High-performance Liquid Chromatography
25%
Type 2 Diabetes Risk
25%
Allele Frequency
25%
Hardy-Weinberg Equilibrium
25%
Chronic Renal Insufficiency
25%
Non-carriers
25%
Low Albumin
25%
Genotypic Distribution
25%
Medicine and Dentistry
Diabetic Nephropathy
100%
Patient with Type 2 Diabetes
100%
Peroxisome Proliferator Activated Receptor
100%
Diabetes
75%
Diabetes Mellitus
50%
Allele
50%
Chronic Kidney Disease
25%
Maturity Onset Diabetes of the Young
25%
Blood Pressure
25%
Hemoglobin A1c
25%
Proteinuria
25%
Genomic DNA
25%
Body Mass Index
25%
Creatinine
25%
High-Performance Liquid Chromatography
25%
Gene Frequency
25%
Age Distribution
25%
Case-Control Study
25%
Odds Ratio
25%
Pharmacology, Toxicology and Pharmaceutical Science
Peroxisome Proliferator Activated Receptor
100%
Diabetic Nephropathy
100%
Non Insulin Dependent Diabetes Mellitus
100%
Diabetes Mellitus
50%
High Performance Liquid Chromatography
25%
Case-Control Study
25%
Chronic Kidney Failure
25%
Creatinine
25%
Genomic DNA
25%
Hemoglobin A1c
25%
Age Distribution
25%
Proteinuria
25%
Biochemistry, Genetics and Molecular Biology
Peroxisome Proliferator-Activated Receptor
100%
Allele
66%
Case-Control Study
33%
Blood Pressure
33%
Glucose Blood Level
33%
Creatinine Blood Level
33%
Gene Frequency
33%
Age Distribution
33%
High-Performance Liquid Chromatography
33%
Genomics
33%